Moon Kil Woong | TalkMarkets | Page 1

Moon Kil Woong

Executive Officer at SME
Moon Kil Woong is currently a VP at a SME. Previously he was a tech stock consultant, VP of Research at ING, and sell side Director at Crédit Agricole Indosuez. Moon Kil Woong has a Masters in Public Administration from SJSU. He contributes to both TalkMarkets and Seeking Alpha. You ...more
Following: 45 Followers: 3193

All Contributions

Latest Posts
1 to 16 of 16 Posts
NeurAxis IPO Sets Stage To Take On Irritable Bowel Syndrome With A Non-Surgical Solution
Monday, February 6, 2023 4:14 PM EDT
As NeurAxis gears up for its upcoming IPO, we take a deep dive into the company to see if it's worth adding to your investment portfolio.
In this article: NRXS Also: ABBV, BMY, AMGN, ARNA, GILD, PFE, TAK
Read
SurgePays Is An Undiscovered Diamond With An Upward Trend
Thursday, July 21, 2022 1:38 PM EDT
SurgePays is an undiscovered diamond with demand, with upcoming profitability, and with a positive stock track.
In this article: SURG
Read
Inhibikase Targets A Substantial Market Following Results Presented At The Barcelona Conference
Monday, March 28, 2022 9:26 AM EDT
The upcoming trial results are expected to show an excellent safety profile of the drug and perhaps some biomarkers that translate into efficacy.
In this article: IKT
Read
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
Monday, October 18, 2021 3:30 PM EDT
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral antivirals
In this article: AZN, JNJ, LLY, MRK, PFE, SNY, INO, RHHBY, NVAX, REGN, GILD, MRNA, AVIR, TOMDF, BNTX, CVAC
Read
PLX Upcoming Volatility Creates Opportunity
Tuesday, July 27, 2021 9:01 AM EDT
PLX was up on FDA notice last year on a CRL postponement that its PDUFA review of PRX-102. In the meantime, phase III trials continue to provide more positive results. It is a stock worth watching.
In this article: PLX Also: INO, DYAI, BCLI, LFMD
Read
Muscle Maker Grill Positioning For Growth Through Acquisition And Expansion
Monday, May 10, 2021 9:16 PM EDT
GRIL is a growing fast food business that is misunderstood as it embanks on rapid expansion using ghost kitchens during the Covid market.
In this article: GRIL Also: GRUB, LYFT, WMT, PZZA, APRN, DASH, CMG
Read
VistaGen Is Prepared For 2021 Fueled By Recent Analyst Upgrades And Large Institutional Buyers
Friday, January 8, 2021 11:59 AM EDT
VistaGen’s deal with Pherin Pharmaceuticals to develop PH-94B has positioned the Company to grab a healthy share of, social anxiety, and major depression markets.
In this article: JNJ, SAGE, CNSP, AXSM, RLMD, VTGN
Read
Ammo Inc.: A Revolution In Shooting Accuracy Catches On
Tuesday, January 5, 2021 6:02 PM EDT
Ammo Inc. is on its way to becoming a powerhouse in the ammunition business spurred by rising demand.
In this article: POWW Also: WMT, VSTO
Read
Is There A Light At The End Of The Tunnel For A COVID-19 Therapeutic?
Tuesday, November 10, 2020 5:47 PM EDT
The corporate culture of CytoDyn Inc. has created an atmosphere where management is now able to realize the full potential of a drug that was essentially tossed in the garbage heap.
In this article: CYDY Also: GILD, LLY, REGN
Read
CytoDyn Investors Sell Despite Positive Recommendation From DSMB And A More Certain Path To COVID-19 Approval
Tuesday, October 20, 2020 2:35 PM EDT
Cytodyn investors are not reacting positively to good news despite being extremely positive.
In this article: CYDY
Read
CytoDyn's Update Provides A Clear Path Towards Approval With Up-Listing Potential Still In The Cards
Friday, September 18, 2020 12:10 PM EDT
This is to clarify the recent conference call and counter misleading information on it by shorters etc.
In this article: CYDY Also: IMMU, GILD
Read
GRIL For Americans Demanding Healthier Fast Food Options: The Evolving Restaurant Landscape Amid The COVID-19 Pandemic
Monday, August 31, 2020 10:00 PM EDT
Food behaviors are changing. GRIL is expanding to adapt.
In this article: GRIL Also: CMG, DNKN, PNRA, BYND, GRUB, LYFT, UBER, FRHHF
Read
There Is Beta In Protalix Stock Due To PRX-102
Monday, August 31, 2020 9:29 AM EDT
Protalix offers positive Beta on PRX-102 success.
In this article: PLX Also: SNY
Read
CytoDyn’s Data: Approvable Drug Sets Stage For Near-Term Move Upward
Monday, August 3, 2020 8:00 PM EDT
Cytodyn, is set to move on positive information and this article gives updated information on why it may move in the near term and an update on their Covid drug trial.
In this article: CYDY Also: GILD, ICPT
Read
HIV Cure Challenger CytoDyn Takes On Gilead Sciences
Friday, July 3, 2020 11:10 AM EDT
CytoDyn believes they have a cure for HIV that will work on a subpopulation of patients with cancer.
In this article: CYDY, GILD Also: MRK
Read
My Take On Recessionary Indicators
Monday, August 11, 2014 5:03 PM EDT
Despite the regularity of economic downturns and the existence of business cycles in a free market economy it is quite obvious that recession calling remains an art more than a science with the scientists being wrong consistently.
In this article: SPX
Read
1 to 16 of 16 Posts